(Total Views: 571)
Posted On: 01/26/2021 12:53:42 PM
Post# of 30034
Todos Medical Ltd. (OTCQB:TOMDF) CEO Gerald Commissiong tells Proactive the in vitro diagnostics company has received a $3.4 million strategic investment from tech-focused venture capital firm Yozma Group Korea.
Commissiong says Todos intends to use the proceeds from the Investment primarily to retire outstanding convertible notes, complete the acquisition of Provista Diagnostics for its Videssa breast cancer test and its COVID-19 PCR testing capabilities, and general working capital.
https://www.youtube.com/watch?v=koXAGE2HkKA
Commissiong says Todos intends to use the proceeds from the Investment primarily to retire outstanding convertible notes, complete the acquisition of Provista Diagnostics for its Videssa breast cancer test and its COVID-19 PCR testing capabilities, and general working capital.
https://www.youtube.com/watch?v=koXAGE2HkKA
(0)
(0)Scroll down for more posts ▼
